Biotech voluntarily disclosed the notice of approval for clinical trials of BAT8006 combined with bevacizumab

SZSI · Aug 28

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.